ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Post-marketing safety profile of Myfembree in approved gynecologic indications: a disproportionality analysis based on the FAERS database.
Xinyu Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.